Medpace Holdings, Inc. is 1.5x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($13.30 B vs $8.97 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRL | MEDP |
|---|---|---|
| Market cap | $8.97 B | $13.30 B |
| US-listed rank | #1006 | #785 |
| Revenue (latest FY) | $4.02B | $2.53B |
| Net income (latest FY) | -$144.34M | $451.12M |
| Net margin | -3.6% | 17.8% |
| P/E (trailing FY) | - | 29.5 |
| SEC filings | 2,387 | 874 |
Medpace Holdings, Inc. is 1.5x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($13.30 B vs $8.97 B).
In their latest fiscal years, CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported $4.02B in revenue while Medpace Holdings, Inc. reported $2.53B.
Full pages: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and Medpace Holdings, Inc., or browse the full rankings.